Standard

B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)

BCL2L11 · rs12711846

What each result means

A/A Published research associates this genotype with typical/baseline likelihood of B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy) — no copies of the reported risk allele.
A/G Published research associates this genotype (one copy of the reported risk allele) with an intermediate association with B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy).
G/G Published research associates this genotype (two copies of the reported risk allele) with a higher likelihood of B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy) compared to the general population.
Source

Questions about rs12711846

What is rs12711846?

rs12711846 is a single position in the genome, in or near the BCL2L11 gene. Published research associates it with b-cell malignancies (chronic lymphocytic leukemia, hodgkin lymphoma or multiple myeloma) (pleiotropy). A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

Does having rs12711846 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs12711846 come from?

GWAS Catalog, Sci Rep 2017, PMID:28112199. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

← See all variants